Equetro: FDA Approved Treatment of Bipolar Disorder

With over two million Americans suffering from mental health symptoms associated with Bipolar disorder, there is an increasing concern and focus over the treatment options available to those Bipolar disorder sufferers struggle to maintain professional lives. From medication to psychotherapy, professional adults suffering daily with Bipolar disorder, are often required to find the right balance, within their own psychological disease managment, to maintain family and career. In an effort to improve the mental health of Bipolar disorder patients, the use of prescription drug Equetro may prove effective in controlling the varying degree of symptoms associated with the life impairing mental health condition.

Bipolar disorder, in an adult, involves a chemical imbalance within the brain which leads to an abnormal mental health response with complications so severe that many sufferers are unable to maintain normal, health lives, at home and at work. For individuals suffering from Bipolar disorder, family members and loved ones will commonly notice symptoms first and describe the bipolar patient as one who experiences a varying degree of moods throughout a day with extreme episodes of mental health complications lasting days, weeks, even months. From extreme highs to extreme lows, the bipolar disorder patient will often experience no sudden event or trigger prior to the mood fluctuation which often leaves many family members and loved ones confused as to how to approach the Bipolar disorder sufferer regarding treatment.

While the cause and origin of Bipolar disorder is specifically unknown, adults suffering from Bipolar disorder will commonly turn to management of mental health conditions through the use of prescription medications. Because prescription medication seemingly improves the chemical imbalance of the brain, associated with Bipolar disorder, many adult mental health sufferers will avert highly recommended psychotherapy as a combination approach to treatment.